Determination of antibodies to pneumococcal c

Pneumococcus is a major cause of community acquired pneumonia

(R) and, according to a recent study >> << maybe the most important agent buy strattera online in agriculture unknown etiology

1.2. Simple to use, rapid, urine-test

identifiable and targeted treatment for 4:00,

meeting hospital quality management initiatives (Health and Welfare

Services). Rapid identification can lead to treatment aimed

solutions to improve treatment results and lower overall health care costs.

Intended use test S. pneumonia is the rapid in vitro

Rapid test for the qualitative detection of antigen S. pneumonia in the urine of patients with pneumonia

and in cerebrospinal fluid (CSF) of patients with

meningitis. In conjunction with the culture and other methods, it

designed to assist in the diagnosis of pneumococcal pneumonia and

and pneumococcal meningitis. Instructions cm

About pneumococcus pneumococcus is the main reason

pneumonia. Pneumococcal pneumonia

mortality reaches 30%, depending on bacteremia, age, and

, underlying disease

1.3. When not properly diagnosed and consider

,

S. pneumonia infection can lead to bacteremia,

meningitis, pericarditis, empyema, purpura Fulminans, endocarditis,

and / or arthritis

4,5. Pneumococcal meningitis, a condition which often leads to

irreversible brain damage or death can occur as a complication of other infections

pneumococcal or may occur spontaneously, without any >> << previous illness. Progression from mild illness

coma can occur within hours, making prompt diagnosis and antimicrobial therapy

critical. For more information about pneumonia, please see link below

: CDC: Infectious Disease Information: Lung Association: Nemours Foundation: KidsHealth. ORG:

For more information about bacterial meningitis, see. Links

below:

CDC: WHO: Nemours Foundation: KidsHealth. ORG:

References 1. Plouffe, J., S. Moore, R. Davis, R. Facklam. Serotypes Streptococcus

blood culture of pneumonia isolated from adult Franklin

County, Ohio. J. Clin. Microbiology, 1994, 32:1606-1607. 2. A. Ruiz-Gonzalez,

, MD, M. Falguera, MD, A. Nogues, MD, M. Rubio-Caballeroa, MD. This

pneumoniae the leading cause of pneumonia of unknown etiology

? Microbiological studies of lung aspirate in patients with

community acquired pneumonia. Am. Bulletin

Med. 1999, 106:385-390. 3. Holmberh, GA Crooke, A. Sjogren. Determination of antibodies to pneumococcal C

polysaccharide in patients with community acquired pneumonia. J. Clin. Microbiology, 1985, 22:808-814. 4. Johnston Jr.,

R. Pathogenesis of pneumococcal pneumonia. Rev. of Infect. Disease

1991; 13 (Supplement 6): S509-S517. 5. Robbins, JB,

, Austria, CJ Lee, SC Rastohi, G. Shyfman I. Henrichsen,

PH Makela, CV Broome, RR Facklam, RH Tiesjema, J. Park, Jr.

. The development of second generation pneumococcal polysaccharide >> << vaccine capsule with a focus on

cross-reactive type groups. J. Infect. Diseases, 1983;

148:1136-1159. 6. Wiselka,

Martin. Specialists view on pneumococcal meningitis .. * Retrospective data. See insert for complete information about performance. .